Home / News / DarioHealth Research Shows Sustained Blood Glucose Improvements Through ML-Powered Digital Engagement 

DarioHealth Research Shows Sustained Blood Glucose Improvements Through ML-Powered Digital Engagement 

Overview 

  • A peer-reviewed study analyzed real-world data from more than 22,000 adults with type 2 diabetes.  
  • The research found that consistent digital engagement was associated with stronger and more sustained improvements in blood glucose.  
  • Machine learning identified actionable engagement patterns that could support more personalized diabetes management.  

The News 

DarioHealth announced the publication of a peer-reviewed study in Frontiers in Digital Health analyzing real-world data from 22,414 adults with type 2 diabetes and high-risk baseline blood glucose levels. Using machine learning and longitudinal analyses, researchers identified distinct patterns of glycemic improvement influenced by demographic, clinical, and engagement factors. 

The study found that frequent blood glucose monitoring and engagement with lifestyle tools were associated with stronger and more sustained improvements. Researchers also identified 12 blood glucose measurements per month as an actionable threshold linked to glycemic improvement. The findings demonstrate how machine learning can help translate real-world engagement data into more personalized diabetes management strategies. 

Industry Perspective 

As digital health moves toward more personalized and data-driven care, real-world evidence and machine learning are helping providers identify which engagement behaviors are most closely associated with improved outcomes. This approach may help shift diabetes management from standardized interventions toward more adaptive support. 

Strategic Impact 

The research strengthens DarioHealth’s position as an evidence-based digital health provider capable of combining machine learning, real-world data, and behavioral engagement to improve diabetes outcomes. The findings could support the company’s value proposition among employers, health plans, and risk-bearing providers seeking scalable solutions with measurable clinical impact. 

Source: PRnewswire 

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *